68
Views
7
CrossRef citations to date
0
Altmetric
Review

Emerging treatment options for early mycosis fungoides

Pages 61-69 | Published online: 18 Feb 2013

References

  • WillemzeRJaffeESBurgGWHO–EORTC classification for cutaneous lymphomasBlood2005105103768378515692063
  • van DoornRvan HaselenCWvan vorst VaderPCMycosis fungoides: disease evolution and prognosis of 309 Dutch patientsArch Dermatol2000136450451010768649
  • OlsenEVonderheidEPimpinelliNRevisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous task force of the European Organization for Research and Treatment of Cancer (EORTC)Blood200711061713172217540844
  • BurgGDummerRHaeffnerAKempfWKadinMFrom inflammation to neoplasia: mycosis fungoides evolved from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumoursArch Dermatol2001137794995211453817
  • DummerRMichieSAKellDExpression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltratesJ Cutan Pathol199522111177751472
  • OlsenEAWhittakerSKimYHClinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United Stated Cutaneous Lymphoma Consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of CancerJ Clin Oncol201129182598260721576639
  • ArdigòMCotaCBerardescaEUnilesional mycosis fungoides succesfully treated with topical imiquimodEur J Dermatol200616444616935811
  • PimpinelliNOlsenEASantucciMDefining early mycosis fungoidesJ Am Acad Dermatol20055361053106316310068
  • HortwitzSMOlsenEADuvicMPorcuPKimYHReview of the treatment of mycosis fungoides and Sezary syndrome: a stage-based approachJ Natl Compr Canc Netw20086443644218433609
  • DummerRDreylingMPrimary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-upAnn Oncol200819Suppl 27276
  • PrinceHMWhittakerSHoppeRTHow I treat mycosis fungoides and Sezary syndromeBlood2009114204337435319696197
  • KayeFJBunnPAJrSteinbergSMA randomized trial comparing combination of electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoidesN Engl J Med198932126178417902594037
  • ZakheimHSKashani-SabetMAminSTopical corticosteroids for mycosis fungoides. Experience in 79 patientsArch Dermatol199813489499549722724
  • WhittakerSJFossFMEfficacy and tolerability of currently avalaible therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphomaCancer Treat Rev200733214616017275192
  • HealdPMelhmauerMMartinAGCrowleyCAYocumRCReichSDTopical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trialJ Am Acad Dermatol200349580181514576658
  • HermanJJRoenigkHHJrHurriaATreatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-upJ Am Acad Dermatol1995332 Pt 1232242
  • HoferACerroniLKerlHWolfPNarrowband (311-nm) UVB therapy for small plaque parapsoriasis and early-stage mycosis fungoidesArch Dermatol199913511377138010566837
  • LindelofBSigurgeirssonBTegnerEPUVA and cancer risk: the Swedish follow-up studyBr J Dermatol1999141110811210417523
  • SternRSNicholsKTVakevaLHMalignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up studyN Engl J Med199733615104110459091799
  • SvanbergKAnderssonTKillanderDPhotodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiationBr J Dermatol199413067437518011500
  • BoehnckeWHKonigKRuckAKauffmanRSterryWIn vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphomaActa Derm Venereol19947432012057915462
  • Rittenhouse-DiakunKVan LeengoedHMorganJThe role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-amino-levulinic acid (ALA)Photochem Photobiol19956155235287770514
  • EdstromDWPortwitARosAMPhotodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological responseActa Derm Venereol200181318418811558874
  • EdstromDWRosAMParvitATopical 5-aminolevulinic acid-based photodynamic therapy for mycosis fungoides: a study of cell proliferation and apoptosis before and after therapyJ Invest Dermatol19981104701
  • AmmannRHunzikerTPhotodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid [letter]J Am Acad Dermatol19953335417657887
  • RecioEDZambranoBAlonsoMLTopical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literatureInt J Dermatol200847441041318377612
  • EichDEichHTOtteTHGhilescuHGStadlerRPhotodynamic therapy of cutaneous T cell lymphoma in specific localizationsHautarzt1999502109114 German10097953
  • WolfPFink-PuchesRCerroniLKerlHPhotodynamic therapy for mycosis fungoides after photosensitization with 5-aminolevulinic acidJ Am Acad Dermatol19943146786808089302
  • WangIBauerBAnderson-EngelsSSvanbergSSvanbergKPhotodynamic therapy utilizing delta aminolevulinic acid in non-melanoma skins malignancies of the eyelid and periocular skinActa Ophthalmol Scand199977218218810321535
  • OrensteinAHaikJTamirJPhotodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical applicationDermatol Surg200026876576910940064
  • MarkhamTSheahanKCollinsPTopical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoidesBr J Dermatol200114461262126311422054
  • LemanJADickDCMortonCATopical 5-ALA therapy for the treatment of cutaneous T-cell lymphomaClin Exp Dermatol200227251651812372098
  • CoorsEAvon den DrieschPTopical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphomaJ Am Acad Dermatol200450336336714988676
  • ZaneCVenturiniMSalaRCalzavara-PintonPPhotodynamic therapy with mehtylaminolevulinate as a value treatment option for unilesional cutaneous T-cell lymphomaPhotodermatol Photoinmunol Photomed2006225254258
  • Fernandez-GuarinoMHartoAPerez-GarciaBMontullCde las HerasEJaenPPlaque-phase mycosis fungoides treated with photodynamic therapy: results in 12 patientsActas Dermosifiliogr20101019785791 Spanish21034709
  • XiaoTXiaLYangZHHeCDGaoXHChenHDNarrow-band ultraviolet B phototherapy for early stage mycosis fungoidesEur J Dermatol200818666066218955199
  • ClarkCDaweRSEvansATLoweGFergusonJNarrowband TL-01 phototherapy for patch-stage mycosis fungoidesArch Dermatol2000136674875210871938
  • PasseronTZakariaWOstovariNEfficacy of the 308-nm excimer laser in the treatment of mycosis fungoidesArch Dermatol2004140101291129315492207
  • KontosAPKerrHAMalickFFivensonDPLimHWWongHK308-nm excimer laser for the treatment of lymphomatoid papulosis and stage IA mycosis fungoidesPhotodermatol Photoinmmunol Photomed2006223168171
  • UpjohnEFoleyPLanePLong-term clearance of patch-stage mycosis fungoides with the 308-nm excimer laserClin Exp Dermatol200732216817117137475
  • PasseronTAngeliKCardot-LecciaNPerrinCLacourJPOrtonneJPTreatment of mycosis fungoides by 308-nm excimer laser: a clinical and histological study in 10 patientsAnn Dermatol Venereol20071343 Pt 1225231 French17389845
  • MeisenheimerJLTreatment of mycosis fungoides using a 308-nm excimer laser: two case studies [letter]Dermatol Online J20061271117459297
  • JinSPJeonYKChoKHChungJHExcimer laser therapy (308 nm) for mycosis fungoides palmaris et plantaris: a skin-directed and anatomically feasible treatmentBr J Dermatol2010163365165320377583
  • NisticoSCostanzoASaracenoRChimentiSEfficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoidesBr J Dermatol2004151487787915491430
  • MoriMCampolmiPMaviliaLRossiRCappugiPPimpinelliNMonochromatic excimer light (308 nm) in patch-stage IA mycosis fungoidesJ Am Acad Dermatol200450694394515153899
  • NisticoSPSaracenoRSchipaniCCostanzoAChimentiSDifferent applications of monochromatic excimer light in skin diseasesPhotomed Laser Surg200927464765419563242
  • GoldbergDJStampienTMSchwartzRAMycosis fungoides palmaris et plantaris: successful treatment with the carbon dioxide laserBr J Dermatol199713646176199155972
  • StanleyMAImiquimod and the imidazoquinolones: mechanism of action and therapeutic potentialClin Exp Dermatol200227757157712464152
  • SchonMPSchonMImiquimod: mode of actionBr J Dermatol2007157Suppl 281318067624
  • SuchinKRJunkins-HopkinsJMRookAHTreatment of stage IA cutaneous T-cell lymphoma with topical application of the immune response modifier imiquimodArch Dermatol200213891137113912224972
  • DummerRUrosevicMKempfWKazakovDBurgGImiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoidesDermatology2003207111611812835571
  • DeethsMJChapmanJTDellavalleRPZengCAelingJLTreatment of patch and plaque stage mycosis fungoides with imiquimod 5% creamJ Am Acad Dermatol200552227528015692473
  • OnsunNUfacikHKuralYTopcuESomayAEfficacy of imiquimod in solitary plaques of mycosis fungoidesInt J Tissue React200527416717216440581
  • Soler-MachinJGilaberte-CalzadaYVera-AlvarezJCoscojuela-SantaliestraCMartinez-MoralesJOsan-TelloMImiquimod in treatment of palpebral micosis fungoidesArch Soc Esp Oftalmol2006814221223 Spanish16688647
  • ChiamLYChamYCSolitary plaque mycosis fungoides of the penis responding to topical imiquimod therapyBr J Dermatol2007156356056217300249
  • CoorsEASchulerGvon den DrieschPTopical imiquimod as treatment for different kinds of cutaneous lymphomaEur J Dermatol200616439139316935796
  • Martinez-GonzalezMCVerea-HernandoMYebra-PimentelMTDel PozoJMazairaMFonsecaEImiquimod in micosis fungoidesEur J Dermatol200818214815218424373
  • DemierreMFVachomLHoVSuttonLCatoALeyland-JonesBPhase 1/2 pilot study of methotrexate-laucopram topical gel for the treatment of patients with early-stage mycosis fungoidesArch Dermatol2003139562462812756099
  • ApisarthanaraxNTalpurRWardSNiXKimHWDuvicMTazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot studyJ Am Acad Dermatol200450460060715034511
  • PeychevaEDaskalowITsonevaIElectrochemotherapy of mycosis fungoides by interferon-αBioelectrochemistry200770228328617150416